Illuminating the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective
Authors:
Open Access
- 24 February 2024
- journal article
- research article
- Published by Elsevier in Neuropeptides
- Vol. 105, 102416
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 221 references indexed in Scilit:
- Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axisNeuropeptides, 2012
- Biased signalling and allosteric machines: new vistas and challenges for drug discoveryBritish Journal of Pharmacology, 2012
- Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420British Journal of Clinical Pharmacology, 2011
- NPY receptors as potential targets for anti‐obesity drug developmentBritish Journal of Pharmacology, 2011
- Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysisHuman Molecular Genetics, 2010
- Ligand-induced Internalization and Recycling of the Human Neuropeptide Y2 Receptor Is Regulated by Its Carboxyl-terminal TailJournal of Biological Chemistry, 2010
- Therapeutic potential of neuropeptide Y (NPY) receptor ligandsEMBO Molecular Medicine, 2010
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug DiscoveryPharmacological Reviews, 2010
- Genome-wide association study suggested copy number variation may be associated with body mass index in the Chinese populationJournal of Human Genetics, 2009
- The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 ReceptorJournal of Biological Chemistry, 2008